» Articles » PMID: 31312367

Suppression of Murine B-cell Lymphoma Growth by Trichosanthin Through Anti-angiogenesis

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2019 Jul 18
PMID 31312367
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Studies have suggested trichosanthin (TCS) exerts antitumor activity mainly through direct cytotoxicity toward cancer cells and immune regulation. In this study, we conducted the proliferation and apoptosis assay on A20 cells and endothelial cells (ECs) with different concentrations of TCS and investigated the levels of gene expression linked to angiogenesis. Herein, a new mechanism that TCS inhibits murine B-cell lymphoma growth by anti-angiogenesis was reported. First, TCS inhibit tumor growth and prolonged survival significantly , and TCS depressed the formation of new blood vessels around the tumor in a dose-dependent manner. Further studies showed that the platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31)-positive endothelial cell numbers, and the serum levels of MMP-2 and MMP-9 were also lower in the study group than controls. However, TCS did neither change the ratio of T cells and NK cells in the spleen of treated mice nor affect the proliferation and apoptosis of A20 cells . Additionally, the newly formed blood vessels in chorioallantoic membranes treated with TCS were significantly reduced. Last, TCS may suppress the proliferation, induce apoptosis and decrease tube formation and migration of endothelial cells (ECs). And, the mRNA and protein levels of VEGF in ECs treated with TCS were lower than that in the control group. These findings confirm that inhibitory effect of TCS on A20 murine B-cell lymphoma growth is mediated via anti-angiogenesis, and which may be associated with the down-regulation of VEGF and MMPs expression. This is an indication that TCS may represent a natural anti-angiogenic drug for lymphoma therapy.

Citing Articles

Study of Water- and Organic-Soluble Extracts from on Type 1 Diabetes Mellitus.

Zhang B, Yuan Y, Xin J, Chen M, Wang Z, Li X J Diabetes Res. 2022; 2022:3250016.

PMID: 35224106 PMC: 8872669. DOI: 10.1155/2022/3250016.


Trichosanthin inhibits cervical cancer by regulating oxidative stress-induced apoptosis.

Zhu C, Zhang C, Cui X, Wu J, Cui Z, Shen X Bioengineered. 2021; 12(1):2779-2790.

PMID: 34233587 PMC: 8806483. DOI: 10.1080/21655979.2021.1930335.

References
1.
Nagase H, Woessner Jr J . Matrix metalloproteinases. J Biol Chem. 1999; 274(31):21491-4. DOI: 10.1074/jbc.274.31.21491. View

2.
Coussens L, Fingleton B, Matrisian L . Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002; 295(5564):2387-92. DOI: 10.1126/science.1067100. View

3.
Jackson C . Matrix metalloproteinases and angiogenesis. Curr Opin Nephrol Hypertens. 2002; 11(3):295-9. DOI: 10.1097/00041552-200205000-00005. View

4.
Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y . Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem. 2002; 277(39):36288-95. DOI: 10.1074/jbc.M201674200. View

5.
Zhang M, Tang H, Guo Z, An H, Zhu X, Song W . Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol. 2004; 5(11):1124-33. DOI: 10.1038/ni1130. View